ERAL1 and breast carcinoma: Recently a monoclonal antibody for GREB1 was created, allowing the detection of a 216 kDa protein whose expression positively correlated to ERα expression in breast cancer cell lines and tumor samples, as well as to GREB1 mRNA transcript levels [31].